Baudax Bio, Inc.
BXRXQ · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $310 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $193 | $50 | $3 | $4,792 |
| Gross Profit | $0 | $0 | $0 | -$4,482 |
| % Margin | – | – | – | -1,445.8% |
| R&D Expenses | $1,708 | $1,729 | $2,917 | $1,037 |
| G&A Expenses | $3,639 | $2,254 | $0 | $0 |
| SG&A Expenses | $3,639 | $2,254 | $1,771 | $2,092 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$3,764 | $3,012 | $0 | $988 |
| Operating Expenses | $1,776 | $7,045 | $4,685 | $4,117 |
| Operating Income | -$1,776 | -$7,045 | -$4,688 | -$8,599 |
| % Margin | – | – | – | -2,773.9% |
| Other Income/Exp. Net | -$115 | -$256 | -$2,698 | -$651 |
| Pre-Tax Income | -$1,891 | -$7,301 | -$7,386 | -$9,250 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,934 | -$7,375 | $11,404 | -$9,250 |
| % Margin | – | – | – | -2,983.9% |
| EPS | -0.3 | -1.51 | 4.91 | -12.33 |
| % Growth | 80.1% | -130.8% | 139.8% | – |
| EPS Diluted | -0.3 | -1.51 | 4.91 | -12.33 |
| Weighted Avg Shares Out | 7,994 | 4,885 | 2,323 | 750 |
| Weighted Avg Shares Out Dil | 7,994 | 4,885 | 2,323 | 750 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $131 | $50 | $3 | $105 |
| EBITDA | -$5,409 | -$4,032 | -$4,685 | -$7,571 |
| % Margin | – | – | – | -2,442.3% |